Cumberland Pharmaceuticals Inc. (CPIX) Stock Overview
Explore Cumberland Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
Cumberland Pharmaceuticals Inc. (CPIX)
Key Financials
Key Financials
Market Cap
114.6M
P/E Ratio
-10.68
EPS (TTM)
$-0.40
ROE
-0.47%
CPIX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cumberland Pharmaceuticals Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CPIX on the NASDAQ shows an RSI of 54.61, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $6.60 for the NASDAQ listing.
Key metrics behind Cumberland Pharmaceuticals Inc.'s NASDAQ-traded stock include a P/E ratio of -10.68 and a market capitalization of 114.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CPIX on the NASDAQ.